Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-05-20 3:21 pm | N/A 2034-01-01 | iSpecimen Inc. | ISPC | Gullans Steven R. Ph.D. Director | 10,000 | $0.53 | 33,525 (Direct) | View |
| 2023-01-01 Option Award | 2023-05-17 12:25 pm | N/A N/A | iSpecimen Inc. | ISPC | Gullans Steven R. Ph.D. Director | 125 | $0 | 3,250 (Direct) | View |
| 2022-10-01 Ownership | 2023-02-10 7:42 pm | N/A N/A | iSpecimen Inc. | ISPC | Gullans Steven R. Ph.D. Director | 625 | $0 | 3,125 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-13 1:00 pm | N/A 2033-01-03 | iSpecimen Inc. | ISPC | Gullans Steven R. Ph.D. Director | 10,000 | $1.41 | 23,525 (Direct) | View |
| 2021-06-21 Ownership | 2022-02-14 3:30 pm | N/A N/A | iSpecimen Inc. | ISPC | Gullans Steven R. Ph.D. Director | 16,025 | $0 | 16,025 (Direct) | View |
Ownership | 2021-06-17 08:49 am | N/A 2031-01-03 | iSpecimen Inc. | ISPC | Gullans Steven R. Ph.D. Director | 0 | $0 | 13,525 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:11 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Gullans Steven R. Ph.D. Director | 60,000 | $0 | 60,000 (Direct) | View |